Evaluation Of Renal Safety Of Raas Inhibitor Therapy: A Clinical And Pharmacovigilant Study

After initiating a renin-angiotensin-aldosterone system (raas) inhibitor, there is a risk of decreased renal functions or hyperkalaemia. Hence, biochemical monitoring tests for serum creatinine and potassium are warranted after therapy initiation and are mandatory by guidelines. However, adherenc...

詳細記述

書誌詳細
第一著者: Khaleel, Mohammad Ali Mohammad
フォーマット: 学位論文
言語:英語
出版事項: 2024
主題:
オンライン・アクセス:http://eprints.usm.my/62705/
Abstract Abstract here

類似資料